| Dr Arin K Greene, MD | |
|
300 Longwood Ave, Hu-158, Boston, MA 02115-5724 | |
| (617) 355-2306 | |
| (617) 738-1657 |
| Full Name | Dr Arin K Greene |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 27 Years |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053385245 | NPI | - | NPPES |
| 2127199 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 205307 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boston Plastic And Oral Surgery | 7517957285 | 8 |
News Archive
ABC News: "Summoning the message back that once mobilized his grass-roots campaign, the president spoke tonight in front of the same people - Organizing for America and DNC members - whose poll show some are feeling somewhat discouraged by the first year of the Obama administration. ... The president outlined in broad strokes what he'd like to see happen [on health reform]. 'What I'd like to do is have a meeting where I'm sitting with the Republicans, sitting with the Democrats.
A breast cancer test has been found that helps doctors make treatment decisions for some breast cancer patients, following research carried out at Queen Mary University of London and funded by Cancer Research UK.
CTI BioPharma Corp. today announced that it has amended its existing loan agreement with Hercules Technology Growth Capital, Inc. (Hercules). Pursuant to the amendment, Hercules agreed to provide term loans in an aggregate principal amount of up to $25.0 million under the facility, inclusive of amounts outstanding immediately prior to closing of the amendment.
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
› Verified 9 days ago
| Entity Name | Boston Plastic & Oral Surgery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568404903 PECOS PAC ID: 7517957285 Enrollment ID: O20040514000467 |
News Archive
ABC News: "Summoning the message back that once mobilized his grass-roots campaign, the president spoke tonight in front of the same people - Organizing for America and DNC members - whose poll show some are feeling somewhat discouraged by the first year of the Obama administration. ... The president outlined in broad strokes what he'd like to see happen [on health reform]. 'What I'd like to do is have a meeting where I'm sitting with the Republicans, sitting with the Democrats.
A breast cancer test has been found that helps doctors make treatment decisions for some breast cancer patients, following research carried out at Queen Mary University of London and funded by Cancer Research UK.
CTI BioPharma Corp. today announced that it has amended its existing loan agreement with Hercules Technology Growth Capital, Inc. (Hercules). Pursuant to the amendment, Hercules agreed to provide term loans in an aggregate principal amount of up to $25.0 million under the facility, inclusive of amounts outstanding immediately prior to closing of the amendment.
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arin K Greene, MD Po Box 414740, Boston Plastic And Oral Surgery, Boston, MA 02241-0001 Ph: (617) 355-2306 | Dr Arin K Greene, MD 300 Longwood Ave, Hu-158, Boston, MA 02115-5724 Ph: (617) 355-2306 |
News Archive
ABC News: "Summoning the message back that once mobilized his grass-roots campaign, the president spoke tonight in front of the same people - Organizing for America and DNC members - whose poll show some are feeling somewhat discouraged by the first year of the Obama administration. ... The president outlined in broad strokes what he'd like to see happen [on health reform]. 'What I'd like to do is have a meeting where I'm sitting with the Republicans, sitting with the Democrats.
A breast cancer test has been found that helps doctors make treatment decisions for some breast cancer patients, following research carried out at Queen Mary University of London and funded by Cancer Research UK.
CTI BioPharma Corp. today announced that it has amended its existing loan agreement with Hercules Technology Growth Capital, Inc. (Hercules). Pursuant to the amendment, Hercules agreed to provide term loans in an aggregate principal amount of up to $25.0 million under the facility, inclusive of amounts outstanding immediately prior to closing of the amendment.
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
› Verified 9 days ago
Hugh G Auchincloss, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2000 | |
Nicole J Look-hong, MD, MSC Surgery Medicare: Medicare Enrolled Practice Location: Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Phone: 617-724-3868 | |
Dr. Paul Jansson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Neville House 236a, Boston, MA 02115 Phone: 617-732-5500 | |
Vanessa Mercedes Welten, MD MPH Surgery Medicare: Medicare Enrolled Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 | |
Dr. Joanna Wolf Etra, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 Francis St Ste 9b, Boston, MA 02215 Phone: 617-632-9513 | |
Jennine Putnick, MD Surgery Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-632-9511 | |
Michael Tarnoff, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 800 Washington St, Nemc Box 7105, Boston, MA 02111 Phone: 617-636-5000 |